← Back to Search

Orthopedic Implant

Tibiotalocalcaneal arthrodesis with DynaNail for Subtalar Arthritis

N/A
Recruiting
Led By ashish shah, md
Research Sponsored by University of Alabama at Birmingham
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 0 - 24 months postoperative
Awards & highlights

Summary

The purpose of this study is to determine the clinical efficacy of a novel dynamic compression intramedullary nail for tibiotalocalcaneal (TTC) arthrodesis

Eligible Conditions
  • Subtalar Arthritis
  • Ankle Arthritis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~0 - 24 months postoperatively
This trial's timeline: 3 weeks for screening, Varies for treatment, and 0 - 24 months postoperatively for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Functional Assessment
Fusion, as measured by radiograph and CT scan
Pain assessment
+1 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Tibiotalocalcaneal arthrodesis with DynaNailExperimental Treatment1 Intervention
Tibiotalocalcaneal arthrodesis with a novel dynamic compression intramedullary nail

Find a Location

Who is running the clinical trial?

University of Alabama at BirminghamLead Sponsor
1,621 Previous Clinical Trials
2,290,945 Total Patients Enrolled
MedShape, IncIndustry Sponsor
7 Previous Clinical Trials
294 Total Patients Enrolled
ashish shah, mdPrincipal InvestigatorUniversity of Alabama at Birmingham
1 Previous Clinical Trials
203 Total Patients Enrolled
~2 spots leftby Jan 2025